These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1567 related articles for article (PubMed ID: 26916730)

  • 1. Inhibition of Orai1 Store-Operated Calcium Channel Prevents Foam Cell Formation and Atherosclerosis.
    Liang SJ; Zeng DY; Mai XY; Shang JY; Wu QQ; Yuan JN; Yu BX; Zhou P; Zhang FR; Liu YY; Lv XF; Liu J; Ou JS; Qian JS; Zhou JG
    Arterioscler Thromb Vasc Biol; 2016 Apr; 36(4):618-28. PubMed ID: 26916730
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chronic infusion of salusin-alpha and -beta exerts opposite effects on atherosclerotic lesion development in apolipoprotein E-deficient mice.
    Nagashima M; Watanabe T; Shiraishi Y; Morita R; Terasaki M; Arita S; Hongo S; Sato K; Shichiri M; Miyazaki A; Hirano T
    Atherosclerosis; 2010 Sep; 212(1):70-7. PubMed ID: 20684826
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Insulin-Like Growth Factor-1 Receptor Deficiency in Macrophages Accelerates Atherosclerosis and Induces an Unstable Plaque Phenotype in Apolipoprotein E-Deficient Mice.
    Higashi Y; Sukhanov S; Shai SY; Danchuk S; Tang R; Snarski P; Li Z; Lobelle-Rich P; Wang M; Wang D; Yu H; Korthuis R; Delafontaine P
    Circulation; 2016 Jun; 133(23):2263-78. PubMed ID: 27154724
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diosgenin inhibits atherosclerosis via suppressing the MiR-19b-induced downregulation of ATP-binding cassette transporter A1.
    Lv YC; Yang J; Yao F; Xie W; Tang YY; Ouyang XP; He PP; Tan YL; Li L; Zhang M; Liu D; Cayabyab FS; Zheng XL; Tang CK
    Atherosclerosis; 2015 May; 240(1):80-9. PubMed ID: 25765596
    [TBL] [Abstract][Full Text] [Related]  

  • 5. DBZ (Danshensu Bingpian Zhi), a Novel Natural Compound Derivative, Attenuates Atherosclerosis in Apolipoprotein E-Deficient Mice.
    Wang J; Xu P; Xie X; Li J; Zhang J; Wang J; Hong F; Li J; Zhang Y; Song Y; Zheng X; Zhai Y
    J Am Heart Assoc; 2017 Oct; 6(10):. PubMed ID: 28971954
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dihydromyricetin ameliorates atherosclerosis in LDL receptor deficient mice.
    Liu TT; Zeng Y; Tang K; Chen X; Zhang W; Xu XL
    Atherosclerosis; 2017 Jul; 262():39-50. PubMed ID: 28500865
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Calpain inhibitor prevents atherosclerosis in apolipoprotein E knockout mice by regulating mRNA expression of genes related to cholesterol uptake and efflux.
    Liu J; Wang Q; Wei Y; Zhang S; Chai E; Tang F
    Microvasc Res; 2022 Mar; 140():104276. PubMed ID: 34742813
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oxidized LDL-induced JAB1 influences NF-κB independent inflammatory signaling in human macrophages during foam cell formation.
    Schwarz A; Bonaterra GA; Schwarzbach H; Kinscherf R
    J Biomed Sci; 2017 Feb; 24(1):12. PubMed ID: 28173800
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rosuvastatin Reduces Aortic Sinus and Coronary Artery Atherosclerosis in SR-B1 (Scavenger Receptor Class B Type 1)/ApoE (Apolipoprotein E) Double Knockout Mice Independently of Plasma Cholesterol Lowering.
    Yu P; Xiong T; Tenedero CB; Lebeau P; Ni R; MacDonald ME; Gross PL; Austin RC; Trigatti BL
    Arterioscler Thromb Vasc Biol; 2018 Jan; 38(1):26-39. PubMed ID: 29162602
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Alteration of volume-regulated chloride channel during macrophage-derived foam cell formation in atherosclerosis.
    Hong L; Xie ZZ; Du YH; Tang YB; Tao J; Lv XF; Zhou JG; Guan YY
    Atherosclerosis; 2011 May; 216(1):59-66. PubMed ID: 21338988
    [TBL] [Abstract][Full Text] [Related]  

  • 11. NG2 Proteoglycan Ablation Reduces Foam Cell Formation and Atherogenesis via Decreased Low-Density Lipoprotein Retention by Synthetic Smooth Muscle Cells.
    She ZG; Chang Y; Pang HB; Han W; Chen HZ; Smith JW; Stallcup WB
    Arterioscler Thromb Vasc Biol; 2016 Jan; 36(1):49-59. PubMed ID: 26543095
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vav Guanine nucleotide exchange factors regulate atherosclerotic lesion development in mice.
    Rahaman SO; Li W; Silverstein RL
    Arterioscler Thromb Vasc Biol; 2013 Sep; 33(9):2053-7. PubMed ID: 23825362
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of glutathione peroxidase-1 deficiency on macrophage foam cell formation and proliferation: implications for atherogenesis.
    Cheng F; Torzewski M; Degreif A; Rossmann H; Canisius A; Lackner KJ
    PLoS One; 2013; 8(8):e72063. PubMed ID: 23991041
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nucleolin protects macrophages from oxLDL-induced foam cell formation through up-regulating ABCA1 expression.
    Li Y; Jiang B; Liang P; Tong Z; Liu M; Lv Q; Liu Y; Liu X; Tang Y; Xiao X
    Biochem Biophys Res Commun; 2017 Apr; 486(2):364-371. PubMed ID: 28315324
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased stability of phosphatase and tensin homolog by intermedin leading to scavenger receptor A inhibition of macrophages reduces atherosclerosis in apolipoprotein E-deficient mice.
    Dai XY; Cai Y; Mao DD; Qi YF; Tang C; Xu Q; Zhu Y; Xu MJ; Wang X
    J Mol Cell Cardiol; 2012 Oct; 53(4):509-20. PubMed ID: 22841663
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Deficiency of adipose differentiation-related protein impairs foam cell formation and protects against atherosclerosis.
    Paul A; Chang BH; Li L; Yechoor VK; Chan L
    Circ Res; 2008 Jun; 102(12):1492-501. PubMed ID: 18483409
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Insulin-like growth factor I reduces lipid oxidation and foam cell formation via downregulation of 12/15-lipoxygenase.
    Sukhanov S; Snarski P; Vaughn C; Lobelle-Rich P; Kim C; Higashi Y; Shai SY; Delafontaine P
    Atherosclerosis; 2015 Feb; 238(2):313-20. PubMed ID: 25549319
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Potent Vasoconstrictor Kisspeptin-10 Induces Atherosclerotic Plaque Progression and Instability: Reversal by its Receptor GPR54 Antagonist.
    Sato K; Shirai R; Hontani M; Shinooka R; Hasegawa A; Kichise T; Yamashita T; Yoshizawa H; Watanabe R; Matsuyama TA; Ishibashi-Ueda H; Koba S; Kobayashi Y; Hirano T; Watanabe T
    J Am Heart Assoc; 2017 Apr; 6(4):. PubMed ID: 28411243
    [TBL] [Abstract][Full Text] [Related]  

  • 19. PKCδ signalling regulates SR-A and CD36 expression and foam cell formation.
    Lin CS; Lin FY; Ho LJ; Tsai CS; Cheng SM; Wu WL; Huang CY; Lian CH; Yang SP; Lai JH
    Cardiovasc Res; 2012 Aug; 95(3):346-55. PubMed ID: 22687273
    [TBL] [Abstract][Full Text] [Related]  

  • 20. EphA2 knockdown attenuates atherosclerotic lesion development in ApoE(-/-) mice.
    Jiang H; Li X; Zhang X; Liu Y; Huang S; Wang X
    Cardiovasc Pathol; 2014; 23(3):169-74. PubMed ID: 24561077
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 79.